Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene US, LLC - The Rare Disease Company United States | 289 | 275 |
|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Myofibrillar myopathy and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 20 | 11 |
|
Myofibrillar myopathy and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 20 | 11 |
|
Myofibrillar myopathy and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 20 | 11 |
|
Myofibrillar myopathy and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 20 | 11 |
|
PreventionGenetics United States | 113 | 106 |
|
PreventionGenetics United States | 64 | 60 |
|
Hypertrophic Cardiomyopathy Panel PreventionGenetics United States | 61 | 56 |
|
Comprehensive Cardiology Panel PreventionGenetics United States | 220 | 196 |
|
Invitae Comprehensive Myopathy Panel Invitae United States | 145 | 70 |
|
Invitae Comprehensive Neuromuscular Disorders Panel Invitae United States | 355 | 208 |
|
Invitae Dilated Cardiomyopathy and Left Ventricular Noncompaction Panel Invitae United States | 135 | 54 |
|
Invitae Cardiomyopathy Comprehensive Panel Invitae United States | 199 | 82 |
|
Invitae Arrhythmogenic Cardiomyopathy Panel Invitae United States | 70 | 22 |
|
Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel Invitae United States | 240 | 100 |
|
Invitae Arrhythmia Comprehensive Panel Invitae United States | 115 | 41 |
|
Comprehensive Cardiac Arrhythmia Panel PreventionGenetics United States | 76 | 63 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.